NL7805647A - Mevalonolactonderivaten, hun gebruik en bereiding. - Google Patents

Mevalonolactonderivaten, hun gebruik en bereiding.

Info

Publication number
NL7805647A
NL7805647A NL7805647A NL7805647A NL7805647A NL 7805647 A NL7805647 A NL 7805647A NL 7805647 A NL7805647 A NL 7805647A NL 7805647 A NL7805647 A NL 7805647A NL 7805647 A NL7805647 A NL 7805647A
Authority
NL
Netherlands
Prior art keywords
mevalonolact
derivatives
preparation
mevalonolact derivatives
Prior art date
Application number
NL7805647A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NL7805647A publication Critical patent/NL7805647A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL7805647A 1977-05-24 1978-05-24 Mevalonolactonderivaten, hun gebruik en bereiding. NL7805647A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6011077A JPS53147073A (en) 1977-05-24 1977-05-24 Mevalonolactone derivatives

Publications (1)

Publication Number Publication Date
NL7805647A true NL7805647A (nl) 1978-11-28

Family

ID=13132633

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7805647A NL7805647A (nl) 1977-05-24 1978-05-24 Mevalonolactonderivaten, hun gebruik en bereiding.

Country Status (9)

Country Link
US (2) US4198425A (nl)
JP (1) JPS53147073A (nl)
BE (1) BE867421A (nl)
DE (1) DE2822848A1 (nl)
ES (1) ES470209A1 (nl)
FR (1) FR2392016A1 (nl)
GB (1) GB1586152A (nl)
NL (1) NL7805647A (nl)
SE (1) SE7805879L (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010951A1 (en) * 1978-10-30 1980-05-14 Sankyo Company Limited 4-Hydroxy-2-pyrone derivatives, process for their preparation and their pharmaceutical preparations

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA18559A1 (fr) * 1978-09-05 1980-04-01 Hoechst Lab Nouveaux derives d'acides carboxyliques 6-alcools, halogenes, leurs procedes de preparation et medicaments les contenant
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4710513A (en) * 1979-08-17 1987-12-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
NZ194557A (en) * 1979-08-17 1984-09-28 Merck & Co Inc Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
US4459422A (en) * 1979-08-17 1984-07-10 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4322563A (en) 1980-04-14 1982-03-30 Merck & Co., Inc. Substituted biphenyl-2-carboxaldehydes
US4308378A (en) * 1980-09-02 1981-12-29 Merck & Co., Inc. Cis/trans isomerization of 6-(substituted-aryl-ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones
US4440927A (en) * 1981-06-19 1984-04-03 Merck & Co., Inc. Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
US5354772A (en) * 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
US4588715A (en) * 1984-06-04 1986-05-13 Sandoz, Inc. Heptenoic acid derivatives
US4588820A (en) * 1984-06-11 1986-05-13 Merck & Co., Inc. Process for epimerization at C6 of 3,4,5,6-tetrahydro-2H-pyran-2-one
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4804679A (en) * 1984-07-24 1989-02-14 Sandoz Pharm. Corp. Erythro-(E)-7-(3'-C1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
US4686237A (en) * 1984-07-24 1987-08-11 Sandoz Pharmaceuticals Corp. Erythro-(E)-7-[3'-C1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US5001255A (en) * 1984-12-04 1991-03-19 Sandoz Pharm. Corp. Idene analogs of mevalonolactone and derivatives thereof
DK22886A (da) * 1985-01-17 1986-07-18 Usv Pharma Corp Arylalkoxyphenyl-allylalkohol til anvendelse mod hypertension
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
JPS6282997A (ja) * 1985-10-04 1987-04-16 株式会社森本製作所 多針式ミシンの縫製装置
US4851427A (en) * 1985-10-25 1989-07-25 Sandoz Pharm. Corp. Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
US4654363A (en) * 1985-11-04 1987-03-31 Merck & Co., Inc. Synthetic analogs of mevinolin
DE3615620A1 (de) * 1986-05-09 1987-11-12 Hoechst Ag 4(r)-substituierte 6(s)-phenoxymethyl-, 6(s)-(beta)-phenylaethyl-und 6(s)-(beta)-styryl-tetrahydropyran-2-one, ein hochstereoselektives verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4808733A (en) * 1986-06-09 1989-02-28 Stauffer Chemical Company Certain 4-oxo-3-benzoylvalerolactones and thiolactones
US4957971A (en) * 1986-07-07 1990-09-18 Warner-Lambert Company Trans-6-(2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl)-or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US5102893A (en) * 1986-07-07 1992-04-07 Warner-Lambert Company Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US4898949A (en) * 1987-02-25 1990-02-06 Bristol-Myers Company Intermediates for the preparation of antihypercholesterolemic tetrazole compounds
US4801611A (en) * 1987-05-07 1989-01-31 G. D. Searle & Co. 5-lipoxygenase inhibitors
US5036105A (en) * 1987-05-07 1991-07-30 G. D. Searle & Co. 5-lipoxygenase inhibitors
US5162365A (en) * 1987-05-07 1992-11-10 G. D. Searle & Co. 5-lipoxygenase inhibitors
US4904646A (en) * 1987-05-22 1990-02-27 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-COA reductase inhibitors
US5091378A (en) * 1987-05-22 1992-02-25 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
DE3722809A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag 3-desmethyl-4-fluor-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung und zwischenprodukte
WO1989003212A1 (en) * 1987-10-13 1989-04-20 Pfizer Inc. 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents
US5169976A (en) * 1987-11-25 1992-12-08 Pfizer Inc. N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents
US4761419A (en) * 1987-12-07 1988-08-02 Warner-Lambert Company 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4863957A (en) * 1987-12-21 1989-09-05 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
US5506219A (en) * 1988-08-29 1996-04-09 E. R. Squibb & Sons, Inc. Pyridine anchors for HMG-CoA reductase inhibitors
US4906657A (en) * 1988-12-21 1990-03-06 Warner-Lambert Company Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
US4957940A (en) * 1988-12-21 1990-09-18 Warner-Lambert Company Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
US5189180A (en) * 1989-09-28 1993-02-23 E. R. Squibb & Sons, Inc. Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
US5025017A (en) * 1989-09-28 1991-06-18 E. R. Squibb & Sons, Inc. Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
WO1992019240A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
WO1992019239A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
IL113567A0 (en) * 1994-05-06 1995-08-31 Upjohn Co Compounds useful to treat retroviral infections
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
US5665333A (en) * 1995-01-17 1997-09-09 Homola; Andrew M. Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
US5961958A (en) * 1996-07-16 1999-10-05 Four Star Partners Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
US20050182125A1 (en) * 2003-05-16 2005-08-18 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
US20040248972A1 (en) * 2003-05-16 2004-12-09 Ambit Biosciences Corporation Compounds and uses thereof
JP2007516227A (ja) * 2003-05-16 2007-06-21 アンビット バイオサイエンシス コーポレーション ピロール化合物およびその使用
US7250444B2 (en) * 2003-08-11 2007-07-31 Pfizer Inc. Pyrrole-based HMG-CoA reductase inhibitors
JP2007513144A (ja) * 2003-12-05 2007-05-24 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー ＨＭＧ−ＣｏＡレダクターゼ阻害剤としてのＮ−アルキルピロール
KR100836960B1 (ko) 2007-09-07 2008-06-10 주식회사 서울제약 새로운 나이아신 제어방출형 제제
US8563066B2 (en) 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
AU2009282051A1 (en) * 2008-08-12 2010-02-18 Castle Beach, L.L.C. Active delivery system formulations
WO2016011297A2 (en) 2014-07-16 2016-01-21 New World Pharmaceuticals, Llc Methods and related compositions for improved drug bioavailability and disease treatment
WO2016056658A1 (ja) * 2014-10-10 2016-04-14 株式会社エーピーアイ コーポレーション スタチン系化合物の精製方法
EP3277274A4 (en) 2015-04-01 2018-12-05 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3119842A (en) * 1961-03-22 1964-01-28 Frank H Hulcher Process for the synthesis of mevalonic acid and its lactone and derivatives thereof
US3075997A (en) * 1961-10-24 1963-01-29 Olin Mathieson 3, 5-dihydroxy-3-fluoro-methylpentanoic acid and the delta lactone thereof
US3346594A (en) * 1965-08-25 1967-10-10 Gen Aniline & Film Corp Haloalkyl and polyhaloalkyl lactones
DE1617812A1 (de) 1967-06-05 1972-02-17 Spezialchemie Gmbh & Co Verfahren zur Herstellung von endoanaesthetisch wirkenden Loesungen von Kava-Wirkstoffen
US3522245A (en) * 1967-07-26 1970-07-28 Spezialchemie Gmbh & Co 4 - oxo - 6 - styryl - 3,4;5,6 - tetrahydro - alpha-pyron compounds,compositions containing same,and process of making same
US3600403A (en) * 1967-11-24 1971-08-17 Spezialchemie Gmbh & Co Hydrogenation of pyrone compounds
FR2098755A5 (en) * 1970-07-27 1972-03-10 Laire Produits Chimie Mevalolactone and its homologues - prepd from 4-hydroxy-2-butanone and an acid
JPS5612114B2 (nl) * 1974-06-07 1981-03-18
JPS5119760A (nl) * 1974-08-09 1976-02-17 Nippon Soda Co

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010951A1 (en) * 1978-10-30 1980-05-14 Sankyo Company Limited 4-Hydroxy-2-pyrone derivatives, process for their preparation and their pharmaceutical preparations

Also Published As

Publication number Publication date
BE867421A (fr) 1978-11-24
ES470209A1 (es) 1979-09-16
JPS6135987B2 (nl) 1986-08-15
DE2822848A1 (de) 1978-11-30
US4198425A (en) 1980-04-15
SE7805879L (sv) 1978-11-25
FR2392016A1 (fr) 1978-12-22
JPS53147073A (en) 1978-12-21
GB1586152A (en) 1981-03-18
US4262013A (en) 1981-04-14

Similar Documents

Publication Publication Date Title
NL7805647A (nl) Mevalonolactonderivaten, hun gebruik en bereiding.
NL7803432A (nl) Aceetamidederivaten.
NL7805346A (nl) Hydroxyalfenonen en hun toepassing als fotosensibilisa- toren.
NO784329L (no) Stilbenderivater.
NL7802671A (nl) Cefemderivaten en hun bereiding.
NL7803296A (nl) Cyclohexaandionderivaten.
NL7807276A (nl) Nieuwe 1-acyl-2-cyaanaziridinen, en werkwijzen voor hun bereiding en toepassing.
NL7800262A (nl) Oxazolinoazetidine derivaten.
DK547378A (da) 1-n-4,6-di-o(aminoglycosyl-)-1,3-dimino-cyclitol-derivater deres fremstilling og anvendelse
NL8002147A (nl) Penem-3-carbonzuurderivaten hun bereiding en gebruik.
NO782832L (no) Antitranspirasjonspreparat.
NL7704174A (nl) Nieuwe m-fenylfenoxypropionzuurderivaten en de bereidingswijze daarvan.
NL7801708A (nl) 1-oxadethiacepham-derivaten.
NL175881B (nl) Braakverwekkend preparaat.
NL7808011A (nl) Norbornaan- en norborneen-derivaten.
IT7820516A0 (it) Agenti stabilizzanti, loro preparazione e loro impiego.
NL7808036A (nl) Nitrosoureum derivaten.
NL7801289A (nl) Oxadiazolopyrimidinederivaten.
NL7811070A (nl) 2-imino-imidazolidinederivaten.
NO780932L (no) Anti-groinsgspreparat.
NL7807215A (nl) Nieuwe daunorubicinederivaten, hun bereiding en prepa- raten met deze derivaten.
NL7604911A (nl) Anthrachinon-bis-amidinen en hun bereiding.
ES234069Y (es) Taco perfeccionado.
NL8004366A (nl) 25-halocholest-5-een-3beta,22-diolen en hun bereiding.
NL7803725A (nl) 4-alkylthio-2-trifluormethylalkaansulfonaniliden en derivaten daarvan.

Legal Events

Date Code Title Description
BV The patent application has lapsed